Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline to Prevent Adverse Remodeling After Acute Myocardial Infarction
NCT03508232Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Jan 2020
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in ST-elevation myocardial infarction (STEMI), sponsored by University of Alberta. Started Jan 2020; status: completed.
02
Drugs
doxycycline
03
Conditions
ST-elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT03508232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508232.